MGMT and central nervous system cancer: Calabrese et al94 predicted the molecular biology of gliomas from conventional MRI data with ASL using a combination of radiomics and CNN features and achieved AUC‐ROCs of 0.97 for identifying ATRX loss, 0.96 for IDH1 mutation, 0.85 for TERT mutation, 0.80 for EGFR amplification, 0.79 for TP53 mutation, and 0.77 for MGMT promoter methylation.